[{"address1": "321 Arsenal Street", "city": "Watertown", "state": "MA", "zip": "02472", "country": "United States", "phone": "339 217 0161", "website": "https://www.iteostherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, an antagonist of T-cell immunoreceptor with Ig and ITIM domains (TIGIT), as well as engages the Fc gamma receptor to activate dendritic cells, natural killer cells, T lymphocytes, and macrophages and to promote the release of cytotoxic granules and antibody-dependent cellular cytotoxicity activity. Its product pipeline also includes inupadenant, a next-generation A2AR antagonist program; EOS-984, a small molecule targeting equilibrative nucleoside transporter 1 (ENT1) to reverse immunosuppression and restore T cell proliferation in the tumor microenvironment; and EOS-215, a monoclonal antibody which antagonizes triggering receptor expressed on triggering receptor expressed on myeloid cells 2. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.", "fullTimeEmployees": 173, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michel  Detheux Ph.D.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 1043774, "exercisedValue": 0, "unexercisedValue": 4750180}, {"maxAge": 1, "name": "Mr. Matthew  Gall", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 648001, "exercisedValue": 0, "unexercisedValue": 1259823}, {"maxAge": 1, "name": "Mr. Matthew A. Call M.B.A.", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 706214, "exercisedValue": 0, "unexercisedValue": 1848175}, {"maxAge": 1, "name": "Dr. Yvonne  McGrath Ph.D.", "age": 50, "title": "Chief Scientific Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Adi  Osovsky", "title": "Executive Vice President of Legal", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philippe  Brantegem", "title": "Executive Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Feltquate M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.18, "open": 5.21, "dayLow": 5.11, "dayHigh": 5.67, "regularMarketPreviousClose": 5.18, "regularMarketOpen": 5.21, "regularMarketDayLow": 5.11, "regularMarketDayHigh": 5.67, "payoutRatio": 0.0, "beta": 1.427, "forwardPE": -0.965812, "volume": 362334, "regularMarketVolume": 362334, "averageVolume": 315115, "averageVolume10days": 372660, "averageDailyVolume10Day": 372660, "bid": 5.6, "ask": 5.69, "bidSize": 1, "askSize": 1, "marketCap": 215797792, "fiftyTwoWeekLow": 4.8, "fiftyTwoWeekHigh": 18.75, "priceToSalesTrailing12Months": 6.1656513, "fiftyDayAverage": 6.8347, "twoHundredDayAverage": 10.305525, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -283684512, "profitMargins": 0.0, "floatShares": 29147629, "sharesOutstanding": 38194300, "sharesShort": 1374925, "sharesShortPriorMonth": 1575148, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.036, "heldPercentInsiders": 0.0113, "heldPercentInstitutions": 0.91196, "shortRatio": 3.71, "shortPercentOfFloat": 0.065, "impliedSharesOutstanding": 38194300, "bookValue": 16.142, "priceToBook": 0.3500186, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -134414000, "trailingEps": -3.32, "forwardEps": -5.85, "enterpriseToRevenue": -8.105, "enterpriseToEbitda": 1.824, "52WeekChange": -0.51955783, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 5.65, "targetHighPrice": 47.0, "targetLowPrice": 15.0, "targetMeanPrice": 23.5, "targetMedianPrice": 19.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 494648000, "totalCashPerShare": 12.951, "ebitda": -155571008, "totalDebt": 5096000, "quickRatio": 12.347, "currentRatio": 12.625, "totalRevenue": 35000000, "debtToEquity": 0.863, "revenuePerShare": 0.865, "returnOnAssets": -0.1447, "returnOnEquity": -0.23065001, "grossProfits": 35000000, "freeCashflow": -64353624, "operatingCashflow": -98181000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -4.48026, "financialCurrency": "USD", "symbol": "ITOS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": -0.0300872, "postMarketPrice": 5.6483, "postMarketChange": -0.00169992, "regularMarketChange": 0.47000027, "regularMarketDayRange": "5.11 - 5.67", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 315115, "fiftyTwoWeekLowChange": 0.8499999, "fiftyTwoWeekLowChangePercent": 0.17708331, "fiftyTwoWeekRange": "4.8 - 18.75", "fiftyTwoWeekHighChange": -13.1, "fiftyTwoWeekHighChangePercent": -0.6986667, "fiftyTwoWeekChangePercent": -51.955784, "earningsTimestamp": 1741176000, "earningsTimestampStart": 1746707400, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.32, "epsForward": -5.85, "epsCurrentYear": -3.77294, "priceEpsCurrentYear": -1.497506, "fiftyDayAverageChange": -1.1847, "fiftyDayAverageChangePercent": -0.17333606, "twoHundredDayAverageChange": -4.6555247, "twoHundredDayAverageChangePercent": -0.45175037, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-07-24", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1595597400000, "postMarketTime": 1744409065, "regularMarketTime": 1744401601, "exchange": "NGM", "messageBoardId": "finmb_663087242", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketChangePercent": 9.073364, "regularMarketPrice": 5.65, "shortName": "iTeos Therapeutics, Inc.", "longName": "iTeos Therapeutics, Inc.", "marketState": "CLOSED", "displayName": "iTeos Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]